Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-nucleoside reverse transcriptase inhibitors

Non-nucleoside reverse transcriptase inhibitors

US Patent 9718819 · Granted Aug 1, 2017

Estimated economic value: $68,609,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antimalarial agents2025
Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of s2025
Antimalarial agents2025
Crystal form of pyrimidine sulfonamide compound and preparation method therefor2025
Small molecule inhibitors of KRAS G12C mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
Aryl sulfonamides as BLT1 antagonists2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2024